Citadel Advisors - CLEARSIDE BIOMEDICAL INC ownership

CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 56 filers reported holding CLEARSIDE BIOMEDICAL INC in Q2 2022. The put-call ratio across all filers is 2.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of CLEARSIDE BIOMEDICAL INC
ValueSharesWeighting
Q3 2023$34,751
-22.0%
39,948
+0.5%
0.00%
Q2 2023$44,534
-56.6%
39,762
-59.7%
0.00%
Q1 2023$102,553
+89.3%
98,609
+103.8%
0.00%
Q4 2022$54,187
+35.5%
48,381
+35.5%
0.00%
Q3 2022$40,000
-54.5%
35,700
-39.8%
0.00%
Q2 2022$88,000
-52.7%
59,266
-27.0%
0.00%
Q1 2022$186,000
-59.6%
81,239
-51.3%
0.00%
Q4 2021$460,000
-79.5%
166,982
-55.3%
0.00%
Q3 2021$2,241,000
+247.4%
373,578
+181.8%
0.00%
Q2 2021$645,000
+120.1%
132,553
+12.1%
0.00%
Q1 2021$293,000
+233.0%
118,225
+268.3%
0.00%
Q4 2020$88,000
+450.0%
32,100
+208.7%
0.00%
Q3 2020$16,000
-95.6%
10,400
-94.6%
0.00%
Q2 2020$362,000
+64.5%
192,586
+48.5%
0.00%
Q1 2020$220,000
-17.9%
129,657
+40.6%
0.00%
Q4 2019$268,000
+294.1%
92,187
+33.0%
0.00%
Q2 2019$68,000
-1.4%
69,311
+38.3%
0.00%
Q1 2019$69,000
-33.7%
50,120
-48.6%
0.00%
Q4 2018$104,000
-55.9%
97,517
+154.9%
0.00%
Q3 2018$236,000
-74.6%
38,259
-56.0%
0.00%
Q2 2018$929,000
-51.4%
86,981
-51.2%
0.00%
-100.0%
Q1 2018$1,912,000
+1534.2%
178,200
+1283.4%
0.00%
Q2 2017$117,00012,8810.00%
Other shareholders
CLEARSIDE BIOMEDICAL INC shareholders Q2 2022
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 2,467,500$14,805,0007.67%
ACUTA CAPITAL PARTNERS, LLC 1,316,268$7,898,0002.79%
AJU IB Investment Co., Ltd. 293,555$1,761,0001.14%
RTW INVESTMENTS, LP 4,206,765$25,241,0000.38%
EAM Investors, LLC 247,561$1,485,0000.25%
Carmignac Gestion 2,475,652$14,854,0000.18%
Curi Wealth Management, LLC 25,000$150,0000.07%
CAXTON ASSOCIATES LP 66,569$399,0000.04%
Newman Dignan & Sheerar, Inc. 21,523$129,0000.04%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 316,600$1,900,0000.04%
View complete list of CLEARSIDE BIOMEDICAL INC shareholders